Inventor · disambiguated record
Luc G. Berthiaume
Also filed as: BERTHIAUME LUC G · BERTHIAUME LUC GERARD
3 granted patents·7 pending applications·1 citations·filing 2012–2025
52Inventor score
Top patents by PatentIndex Score
10 records- 0169US11135218B2Synthetic lethality and the treatment of cancerPACYLEX PHARMACEUTICALS INC·Filed 2018·Granted Oct 5, 2021·1 cites·6 claims
- 0269US2023374603A1Synthetic lethality and the treatment of cancerPACYLEX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0365US2025179589A1Synthetic lethality and the treatment of cancerPACYLEX PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0463US12343341B2Synthetic lethality and the treatment of cancerPACYLEX PHARMACEUTICALS INC·Filed 2021·Granted Jul 1, 2025·0 cites·11 claims
- 0555US2019010555A1Synthetic lethality and the treatment of cancerPACYLEX PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0655US2015275309A1Synthetic lethality and the treatment of cancerPACYLEX PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 0746US2024350481A1Use of n-myristoyl transferase (nmt) inhibitors in the treatment of cancer, autoimmune disorders, and inflammatory disordersPACYLEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0839US2014227284A1Synthetic lethality and the treatment of cancerBERTHIAUME LUC G·Filed 2012·Application pending·0 cites
- 0937US11788145B2Epigeneiic silencing of NMT2PACYLEX PHARMACEUTICALS INC·Filed 2016·Granted Oct 17, 2023·0 cites·8 claims
- 1035US2015218648A1Methods and compositions for diagnosis and prognosis in breast cancerPACYLEX PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Luc G. Berthiaume files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →